Lorenzo Dottorini (@lorenzodotto) 's Twitter Profile
Lorenzo Dottorini

@lorenzodotto

Geriatric Oncologist at ASST-Bergamo Ovest Treviglio #OldLivesMatter

ID: 1165225135

calendar_today10-02-2013 07:35:39

317 Tweet

208 Followers

140 Following

Journal of Geriatric Oncology (@jgerionc) 's Twitter Profile Photo

The role of serum albumin in predicting hospitalization risk after chemotherapy geriatriconcology.net/article/S1879-… William Dale, MD, PhD, FASCO @rochgerionc Cancer and Aging Research Group (CARG) #GeriOnc #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #RiskPrediction #CARG

The role of serum albumin in predicting hospitalization risk after chemotherapy geriatriconcology.net/article/S1879-… <a href="/WilliamDale_MD/">William Dale, MD, PhD, FASCO</a> @rochgerionc <a href="/myCARG/">Cancer and Aging Research Group (CARG) #GeriOnc</a> #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #RiskPrediction #CARG
Young SIOG (@youngsiog) 's Twitter Profile Photo

The abstract submission for the Annual #SIOG Conference is OPEN! 🗓️ 17-19 oct 2024 📍Montréal, Canada Share your research with other YSIOG members and submit your abstract via: siog.org/events/siog-ev…

Lorenzo Dottorini (@lorenzodotto) 's Twitter Profile Photo

Happy to share our last work about prostatectomy Vs RT Vs observation in older patients. Congrats to faupe for the great work and thanks to the Journal of Geriatric Oncology staff. authors.elsevier.com/c/1j9Me6hK~08W… Nicolò Battisti, MD @rochgerionc @G_LipositsMD

Lorenzo Dottorini (@lorenzodotto) 's Twitter Profile Photo

Congrats to faupe and colleagues. Vitamin D supplementation reduce total cancer mortality! Strong evidence for thyroid and renal cancer, highly suggestive evidence for many others. Maybe Vit D is deeply underestimated in oncology treatment and prevention? authors.elsevier.com/c/1jftO8Yy15AN…

SIOG (@siogorg) 's Twitter Profile Photo

There are just a few days until #ESMO24! We're looking forward to seeing many colleagues and friends. Stop by the #SIOG stand S314 to say hi! Psst. We're offering special ESMO24 discounts on SIOG memberships. Spread the word. See you then!

There are just a few days until #ESMO24! We're looking forward to seeing many colleagues and friends. Stop by the #SIOG stand S314 to say hi! Psst. We're offering special ESMO24 discounts on SIOG memberships. Spread the word. See you then!
Bishal Gyawali, MD, PhD, FASCO (@oncology_bg) 's Twitter Profile Photo

Every time they approve a drug based on non-survival endpoint, they give us some excuse. I have collected those excuses. There are seven of them. In this new column in Medscape , I and Dr. Sharon Batt, a cancer survivor and regulatory science expert, list these seven arguments

Every time they approve a drug based on non-survival endpoint, they give us some excuse. I have collected those excuses. There are seven of them.
In this new column in <a href="/Medscape/">Medscape</a> , I and Dr. Sharon Batt, a cancer survivor and regulatory science expert, list these seven arguments